SREBF1 and liver cancer: β2SP drives lipogenesis, fibrosis, and liver cancer development in metabolic dysfunction–associated steatotic liver disease through interaction with, and caspase-3–mediated cleavage of, sterol regulatory element-binding protein 1 (SREBP1).